SSA
IPSC icon

Schonfeld Strategic Advisors’s Century Therapeutics IPSC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.8K Buy
+21,532
New +$49.2K ﹤0.01% 2377
2024
Q2 		– Sell
-93,085
Closed -$389K – 2348
2024
Q1 		$389K Buy
+93,085
New +$394K ﹤0.01% 1563
2022
Q1 		– Sell
-12,300
Closed -$195K – 2740
2021
Q4 		$195K Sell
12,300
-1,300
-10% -$24.4K ﹤0.01% 1747
2021
Q3 		$342K Sell
13,600
-4,500
-25% -$122K ﹤0.01% 1460
2021
Q2 		$531K Buy
+18,100
New +$459K 0.01% 1161

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Schonfeld Strategic Advisors's IPSC Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Century Therapeutics (IPSC) in Q2 2026: 21,532 shares worth $52.8K. The stake represents ﹤0.01% of the portfolio and ranks #2377 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in IPSC as recently as Q1 2024.

Schonfeld Strategic Advisors first reported a position in IPSC in Q2 2021 and has held it in 5 quarters since. The position peaked at $531K in Q2 2021. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Schonfeld Strategic Advisors held 21,532 shares of Century Therapeutics worth $52.8K as of Q2 2026.
  • Century Therapeutics was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2377 holding.
  • Schonfeld Strategic Advisors first reported a position in Century Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • Schonfeld Strategic Advisors's Century Therapeutics position peaked at $531K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.